Darwin Global Management, Ltd. — Q2 2023 13F-HR

← Darwin Global Management, Ltd.

Q2 2023 · 13F-HR

Darwin Global Management, Ltd.holdings as filed

Filed 2023-08-14 · accession 0001892688-23-000068

$611.7M

Reported value

Positions

2023-06-30

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
02290A102	—	AMBRX BIOPHARMA INC	$274.7M	44.9%	16,688,636	Common	SOLE
88322Q108	TGTX	TG THERAPEUTICS INC	$230.5M	37.7%	9,278,439	Common	SOLE
04016X101	ARGX	ARGENX SE	$106.5M	17.4%	273,343	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.